CHAPTER 115

CHAPTER 115
Anna's PoV

The email from the university consortium sat open on my laptop for three days while I wrestled with the decision. Don Vincenzo and Sofia had been supportive but honest about their concerns, which made the choice even more complicated.

"I think you should do it if you want to," Sofia had said. "But I also think you should make sure you can still come to my drama performances and have family dinners with us."

Don Vincenzo's perspective was more nuanced. "This opportunity could define your career and help countless people. But you need to be honest with yourself about whether you are taking it because you truly want it or because you feel obligated to say yes to every request for help."

His question struck at the heart of my uncertainty. Was I drawn to this position because it aligned with my professional goals, or was I unable to say no to an opportunity that would help others even if it came at personal cost?

I spent a session with Dr. Chen exploring these questions.

"What would accepting this position mean for your ongoing healing work?" Dr. Chen asked.

"I would need to be very disciplined about maintaining boundaries," I replied. "The role would require more time and energy than my current work, but it would also give me resources and support that I do not have now."

"And what would declining mean?"

"That I am prioritizing my family and personal healing over professional advancement," I said. "Which might be the right choice, but it also feels like I am letting fear control my decisions."

Dr. Chen leaned back in her chair. "Anna, there is no objectively correct choice here. Either decision involves trade-offs. The question is which trade-offs you can live with and which align with your values and current life stage."

After much reflection and discussion with my family, I decided to respond to the consortium with specific conditions. I would accept the position only if they agreed to certain boundaries: no more than thirty hours per week, protected time for family commitments, and the ability to maintain my own therapy schedule.

"These are reasonable requests," I explained to the consortium's search committee during a video call. "I have learned that I cannot help others effectively if I am not taking care of myself and my family. If you need someone who can work sixty hours per week, I am not the right person. But if you want someone who can build sustainable, effective programs while modeling healthy work-life balance, then I am very interested."

To my surprise, the search committee was enthusiastic about my conditions.

"We actually appreciate your clarity about boundaries," the committee chair said. "Too many leaders in this field burn out because they feel they must sacrifice everything for the work. Your approach is exactly what we need for a trauma-informed program."

They offered me the position with all my conditions accepted and a few additional supports I had not even requested, including an administrative assistant and a professional development budget that would allow me to continue my own training and therapy.

I accepted the position with a mixture of excitement and trepidation. The work would begin in six weeks, giving me time to wrap up current commitments and prepare mentally for the transition.

"I am proud of you, Mom," Sofia said when I told her the news. "And I am also proud that you made sure you could still be our mom first and the director second."

Don Vincenzo was equally supportive. "This is the right opportunity at the right time. You are ready for this."

The first few weeks in my new role were both exhilarating and overwhelming. The hospital where the trauma-informed therapy program was based was one of the largest medical centers in the region, with thousands of employees and complex organizational politics.

My primary responsibility was designing and implementing therapeutic programs for trauma survivors while also training hospital staff on trauma-informed care principles. The work was meaningful and aligned perfectly with my expertise and experience.

I assembled a small team of therapists and administrators who shared my vision for the program. We developed protocols, created training materials, and began implementing changes in how the hospital approached trauma treatment.

But about six weeks into my new position, I discovered something that made my blood run cold.

I was reviewing budget documents and noticed that the hospital's main research funding came from a pharmaceutical company called Meridian Health Solutions. The name sounded vaguely familiar, so I did some research.

Meridian Health Solutions had been founded ten years ago by several executives who had previously worked at pharmaceutical companies that had been connected to Adams's network. While there was no direct evidence of wrongdoing, the connections were too close for comfort.

I dug deeper into the hospital's relationship with Meridian. The pharmaceutical company provided significant funding for research programs and had representatives on several hospital committees. They also supplied many of the medications used in the hospital's psychiatric units.

My concerns deepened when I discovered that Meridian had been promoting a new class of psychiatric medications that hospital doctors were increasingly prescribing to trauma patients. The medications were described as breakthrough treatments for PTSD and complex trauma, but the research supporting them was mostly funded by Meridian itself.

I brought my concerns to Dr. Patricia Williams, the hospital's chief of psychiatry and my direct supervisor.

"Dr. Williams, I need to talk to you about Meridian Health Solutions," I said during a private meeting in her office.

"What about them?" she asked, her expression neutral.

"I have discovered that the company was founded by people who worked at pharmaceutical firms connected to a criminal network I was involved in exposing several years ago," I explained. "I am concerned about their influence over hospital treatment protocols."

Dr. Williams frowned. "That is a serious accusation. Do you have evidence that Meridian is engaged in any wrongdoing?"

"Not direct evidence," I admitted. "But the connections are concerning enough that I think we should scrutinize their research and influence more carefully."

"Anna, I understand your history makes you sensitive to pharmaceutical manipulation," Dr. Williams said carefully. "But Meridian is a legitimate company with FDA-approved products. We cannot reject their partnership based solely on your suspicions about past associations of their founders."

"I am not suggesting we reject their partnership immediately," I replied. "I am suggesting we implement stronger oversight of their research funding and critically examine the medications we are prescribing based primarily on their studies."

Dr. Williams agreed to review the hospital's relationship with Meridian, but I could tell she thought I was being paranoid. Her skepticism reminded me uncomfortably of how authorities had initially dismissed my concerns about Adams.

I decided to do my own quiet investigation. Using the research skills I had developed during my work exposing Adams's network, I began examining Meridian's published studies, looking for signs of data manipulation or questionable methodology.

What I found was subtle but concerning. Several studies showed unusual patterns in their results that suggested possible selective reporting of data. Patient populations in the studies did not always match the demographics of people who would actually use these medications. And some of the researchers involved had received significant financial compensation from Meridian beyond standard research grants.

I compiled my findings into a detailed report and scheduled another meeting with Dr. Williams. But before that meeting could happen, I received an unexpected visitor at my office.

A man in his fifties wearing an expensive suit appeared at my door without an appointment. "Dr. Sinclair, I am David Chen, vice president of research at Meridian Health Solutions. I understand you have been investigating our company."

My heart started racing. "How did you know about my research?"

"We monitor mentions of our company name in hospital communications," he said smoothly. "Standard practice for protecting our intellectual property and reputation. I wanted to address your concerns directly before they lead to any misunderstandings."

The fact that Meridian was monitoring hospital communications was itself concerning. "I am not trying to create misunderstandings," I said carefully. "I am trying to ensure that the medications prescribed to vulnerable trauma patients are safe and effective."

"Of course," David Chen replied. "And I can assure you that all our products meet the highest standards of safety and efficacy. Perhaps I could provide you with additional research data that might address your questions?"

His offer sounded reasonable, but something about his demeanor reminded me of the smooth, manipulative way Adams had spoken. The way he framed my concerns as misunderstandings rather than legitimate questions. The way he appeared at my office to address issues before I could raise them through official channels.

"Thank you for the offer," I said. "But I prefer to review research through peer-reviewed publications rather than materials provided directly by the pharmaceutical company."

David Chen's smile did not quite reach his eyes. "Of course. I just hope your personal history does not cloud your professional judgment about our company. It would be unfortunate if unfounded concerns disrupted the hospital's important research partnerships."

After he left, I sat at my desk feeling shaken. I accepted the position but discovered the hospital had connections to pharmaceutical companies that reminded me uncomfortably of Adams's network.